Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

FDA Cancels Series Of Town Hall Meetings Following Commissioner Crawford’s Resignation

This article was originally published in The Pink Sheet Daily

Executive Summary

The agency has no immediate plans to reschedule the public meetings, which were intended to help shape the agency’s agenda for 2006.

You may also be interested in...



FDA Stresses Stability Following Commissioner Crawford's Resignation

HHS Secretary Leavitt praises Crawford and Acting Commissioner von Eschenbach while underscoring the experienced leadership remaining at the agency in a memo to FDA staff.

Crawford Resigns; NCI Director Von Eschenbach Named To Top FDA Spot

Von Eschenbach appointed to be acting FDA commissioner following the Sept. 23 resignation of Lester Crawford.

FDA Postpones Crawford’s Road Show

FDA Commissioner Lester Crawford has postponed a public workshop that was originally scheduled for Sept. 13 in Miami, Fla., the agency announced Sept. 7

Related Content

Topics

UsernamePublicRestriction

Register

PS062951

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel